The Estée Lauder Companies Names Michael O’Hare Executive Vice President, Global Human Resources

The Estée Lauder Companies Inc. (NYSE:EL) announced today the appointment of Michael O’Hare as Executive Vice President, Global Human Resources. Mr. O’Hare will report jointly to William P. Lauder, Executive Chairman, and Fabrizio Freda, President and Chief Executive Officer. He assumes his new position on September 30, 2013.

Mr. O’Hare joins the"...

New lifeline for displaced Syrians as HH Sheikha Jawaher launches ‘Big Heart for Syrian refugee children’ campaign to give over 1.65 million refugees hope beyond World Refugee Day

With the global community marking World Refugee Day on June 20th, Her Highness Sheikha Jawaher Bint Mohammed Al Qasimi, Wife of the Ruler of Sharjah and Chairperson of the Supreme Council for Family Affairs and UNHCR Eminent Advocate for Refugee Children has made the Syrian refugee crisis her immediate focus by launching the ‘Big Heart for Syrian refugee children’ campaign.

According"...

Quintiles Named a “Best Place to Work in IT” by Computerworld for Fifth Time

Quintiles (NYSE: Q) has been named to IDG’s Computerworld “100 Best Places to Work in IT” list for the fifth time.

Computerworld has recognized the top 100 companies for information technology professionals since 1994 based on criteria such as diversity, career development, training and retention.

Covidien Announces Publication of Final Results of Pipeline™ Embolization Device Pivotal Study

Covidien (NYSE:COV), a leading global provider of healthcare products, today announced that the final results of the PUFs (Pipeline for Uncoilable or Failed Aneurysms) clinical study of its Pipeline™ embolization device"......

The WIN Consortium in Personalized Cancer Medicine Welcomes the Blue Cross and Blue Shield Association as Its First Health Plan Member

The Worldwide Innovative Networking (WIN) Consortium, a leader in personalized cancer medicine, today proudly announced that the Blue Cross and Blue Shield Association (BCBSA), an association of thirty-eight independent Blue Cross and Blue Shield companies, has become a member of the consortium. Founded on the recognition that greater success can be achieved through collaboration than any organization can achieve alone, the WIN Consortium is a global network of leading academic, industry, insurance and patient advocacy organizations"...

Oral Anti-Cancer Therapy REVLIMID® (lenalidomide) Now Indicated as a Treatment for Patients with Rare Form of Blood Disease

Celgene International Sàrl (NASDAQ: CELG) was today notified that the European Commission (EC) has amended the marketing authorisation for REVLIMID®. This decision means that REVLIMID is now approved to treat patients with transfusion-dependent anaemia due to low or intermediate-1 risk myelodysplastic syndromes (MDS) associated with an isolated deletion 5q cytogenetic abnormality when other therapeutic options are insufficient or inadequate.1

New long-term data reinforce safety profile of Pradaxa® for stroke prevention in AF

• Published online in Circulation, results from RELY-ABLE®, the RE-LY® extension study, support long-term safety of Pradaxa® (dabigatran etexilate) in patients with non-valvular atrial fibrillation
• Pradaxa® is the only novel oral anticoagulant with controlled long-term clinical trial data extending beyond 4 years of ongoing treatment
• The long-term results contribute to the growing body of data reinforcing Pradaxa® as an important advancement in the treatment of patients with atrial fibrillation compared to warfarin1

Boehringer Ingelheim’s investigational all-oral interferon-free combination achieved 95% viral cure rates in genotype-1b hepatitis C patients

For media outside USA, UK and Canada only

• In the Phase IIb SOUND-C3 study, all but one patient achieved viral cure with faldaprevir+ and deleobuvir+ (BI 207127) plus ribavirin, without a need for interferon
• The study included challenging-to-cure patients with advanced liver disease, all of whom achieved viral cure

New data from Boehringer Ingelheim’s"...

Abu Dhabi Police Airlifts a Citizen from Ibri to Tawam

The Air Ambulance aircraft of the Abu Dhabi Police’s Air Wing Department airlifted an Emirati woman who had sustained injuries in a traffic accident, from Ibri hospital in the Sultanate of Oman to Tawam hospital in Al Ain to receive necessary medical treatment.

This comes in line with the humanitarian missions provided by the Department to the public.

Boehringer Ingelheim and Eli Lilly and Company Alliance to Feature 34 Presentations in Type 1 and Type 2 Diabetes at the 73rd American Diabetes Association Scientific Sessions®

Ex US & UK Medical Media Only

Boehringer Ingelheim and Eli Lilly and Company are pleased to announce that the companies’ diabetes alliance will have a strong scientific and clinical presence at the 73rd American Diabetes Association (ADA) Scientific Sessions® in Chicago, 21–25 June, with 34 posters, abstracts and an oral presentation.

Empagliflozin*"...